SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-115292
Filing Date
2023-04-25
Accepted
2023-04-25 16:06:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d420328ddefa14a.htm DEFA14A 13966
2 GRAPHIC g420328g06i88.jpg GRAPHIC 195779
3 GRAPHIC g420328g81v32.jpg GRAPHIC 132082
  Complete submission text file 0001193125-23-115292.txt   466641
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38443 | Film No.: 23844910
SIC: 2834 Pharmaceutical Preparations